Previous Article | Next Article ![]()
Applied and Environmental Microbiology, November 1998, p. 4482-4484, Vol. 64, No. 11
Bioactive Agents Research, National Center
for Agricultural Utilization Research, REE, Agricultural Research
Service, U.S. Department of Agriculture, Peoria, Illinois
61604,1 and
Department of Chemistry,
University of Iowa, Iowa City, Iowa 522422
Received 18 May 1998/Accepted 3 September 1998
The mycoparasite Humicola fuscoatra NRRL 22980 was
isolated from a sclerotium of Aspergillus flavus that had
been buried in a cornfield near Tifton, Ga. When grown on autoclaved
rice, this fungus produced the antifungal metabolites
monorden, monocillin IV, and a new monorden analog. Each metabolite
produced a clear zone of inhibition surrounding paper assay disks on
agar plates seeded with conidia of A. flavus. Monorden was
twice as inhibitory to A. flavus mycelium extension
(MIC > 28 µg/ml) as monocillin IV (MIC > 56 µg/ml).
Cerebrosides C and D, metabolites known to potentiate the activity of
cell wall-active antibiotics, were separated from the ethyl
acetate extract but were not inhibitory to A. flavus when
tested as pure compounds. This is the first report of natural products
from H. fuscoatra.
0099-2240/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Antifungal Metabolites (Monorden, Monocillin IV, and
Cerebrosides) from Humicola fuscoatra Traaen NRRL 22980, a Mycoparasite of Aspergillus flavus Sclerotia
*
Corresponding author. Mailing address: Bioactive
Agents Research, REE, ARS, NCAUR, USDA, 1815 N. University
St., Peoria, IL 61604. Phone: (309) 681-6243. Fax: (309)
681-6686. E-mail:
wicklodt{at}mail.ncaur.usda.gov.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»